when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Sanofi ($SNY) · news · pharmadog

← back to Sanofi

News mentioning $SNY

149 stories

28dSanofi nixes Kymab-originated OX40L antibody in atopic dermatitisendpoints

28dSanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyoutfiercebiotech

28dScribe records upsized $129M IPO to bankroll lipid-lowering genetic medsfiercebiotech

28dChutes & Ladders—Biogen R&D vet gets in Formationfiercebiotech

28dSTAT+: Popular insulin product enters shortage as other pens leave marketstat

29d6 companies hiring in Cambridge nowbiospace

Jul 22, 26FDA issues untitled letters to Sanofi and Viatris for false advertisingraps

Jul 20, 26Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic medsfiercebiotech

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 17, 26Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesbiopharma dive

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 16, 26Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patentsendpoints

Jul 15, 26J&J dips despite upbeat outlook; AstraZeneca, Spero cut China dealsbiopharma dive

Jul 15, 26STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and morestat

Jul 14, 26STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded accessstat

Jul 14, 26STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last yearstat

Jul 14, 26STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and morestat

Jul 13, 26STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patentsstat

Jul 13, 26Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahomastat

Jul 13, 26STAT+: All eyes on data on Biogen’s tau therapystat

Jul 13, 26STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and morestat

Jul 10, 26Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injectorendpoints

Jul 8, 26Sanofi offers to end disparaging claims against CSL flu shot in Europeendpoints

Jul 6, 26Gene editing developer Scribe plots an IPObiopharma dive

Jul 1, 26FDA warns Genzyme's Irish site over quality questionsendpoints

Jun 30, 26These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.biopharma dive

Jun 30, 26STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and morestat

Jun 30, 26Sanofi’s Lumizyme successor passes Phase 3 test in babies with Pompe diseaseendpoints

Jun 29, 26STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney generalstat

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

← prevpage 3 of 5next →